Named Patient Program for Olverembatinib (HQP1351)
Clinical trial NCT05594758 · AVAILABLE
Trial details
- NCT number
- NCT05594758
- Sponsor
- Ascentage Pharma Group Inc.
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.